A Parallel, Double-blind, Placebo Controlled, Randomized Comparison of an Anti-Digoxin Antibody (Digibind) Versus Placebo for the Treatment of Antepartum Patients With Severe Preeclampsia.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Jul 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 Jan 2011 Results have been published (American Journal of Perinatology; 27(8): 655-662).
25 Sep 2008 Additional analysis presented at the 16th World Congress of the International Society for the Study of Hypertension in Pregnancy in Sep 2008.
22 Jul 2008 Data are under review by a potential licensing partner; In addition, data from the study will be presented in international conferences later this year, reported by Protherics in a media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com